CytRx Reaches Patient Enrollment Target In Global Phase 2b Clinical Trial With ... BioResearch Online (press release) CytRx Reaches Patient Enrollment Target In Global Phase 2b Clinical Trial With Tamibarotene As First-Line Treatment For Non-Small-Cell Lung Cancer. February 28, 2013. LOS ANGELES--(BUSINESS WIRE)-- ... Patients with stage IIIB or IV squamous or ... |
